08-10-2005, 07:00 AM
|
|
Registered User
|
|
Join Date: Jan 2003
Posts: 1,438
Thanks: 7
Thanked 115 Times in 67 Posts
|
|
|
Johns Hopkins to test new blood product
http://baltimore.bizjournals.com/bal...ml?jst=b_ln_hl
July 19, 2005
Johns Hopkins to test new blood product
Alan Zibel
Staff
Johns Hopkins University's medical school will conduct a 40-patient trial for an artificial blood product developed by a California firm.
San Diego-based Sangart Inc., announced Tuesday a Phase II clinical trial for its product, Hemospan, which is designed to deliver oxygen to body tissues without the need for a blood transfusion.
The product is designed to overcome the problem of blood shortages and avoid transmission of diseases, according to the company. Sangart also says it is compatible among all blood types and can be stored indefinitely.
Dr. Robert Winslow, an expert in the field of oxygen transport, founded Sangart in 1998.
__________________
Mr. Jan B. Wade
Blood Management Consultant
Enhance Outcomes - Control Cost
For Information Call - 360 296-1807
Email
|
You are currently accessing this Site as a guest. Please login or register by clicking Here
Linear Mode
